Skip to main content
Equibles

Anne Prener, M.D., Ph.D.

Board Member

Keros Therapeutics, Inc. (KROS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Keros Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get KROS alerts

About Anne Prener, M.D., Ph.D.

Anne Prener, M.D., Ph.D. is recorded as Board Member at Keros Therapeutics, Inc. (KROS) since July 1, 2026. Keros Therapeutics, Inc. reported in an 8-K filed June 25, 2026 that Anne Prener, M.D., Ph.D. was appointed director, effective July 1, 2026. Keros Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Keros Therapeutics, Inc. includes Jasbir Seehra (CEO, Chairman and Board Member), Jean-Jacques Bienaimé (Chairman and Board Member), Annita Tanini (Chief Accounting Officer) and 3 others.

“On June 23, 2026, the board of directors (the "Board") of Keros Therapeutics, Inc. (the "Company"), based upon a recommendation from the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), voted to appoint Anne Prener, M.D., Ph.D., as a director of the Company, effective on July 1, 2026.”
Keros Therapeutics, Inc. Form 8-K, filed June 25, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Keros Therapeutics, Inc.

Recent activity